Catalyst Wire Dossier Catalyst Wire Dossier

Grass pollen allergen extract sublingual immunotherapy

grass pollen allergen extract · Allergopharma GmbH & Co. KG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Grass pollen allergen extract sublingual immunotherapy, covering 2015-10-16 to 2015-10-16. Get the full timeline:

Most recent: Clinical Trial Update: Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children [Phase 3]

See pricing